Browse by People

Collapse authors list.
Hillmen, Peter, Rawstron, Andy C, Brock, Kristian, Muñoz-Vicente, Samuel, Yates, Francesca J, Bishop, Rebecca, Boucher, Rebecca, MacDonald, Donald, Fegan, Christopher, McCaig, Alison et al (show 9 more authors) , Schuh, Anna, Pettitt, Andrew, Gribben, John G, Patten, Piers EM, Devereux, Stephen, Bloor, Adrian, Fox, Christopher P, Forconi, Francesco and Munir, Talha (2019) Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: The CLARITY Study. Journal of Clinical Oncology, 37 (30). pp. 2722-2730.

Collapse authors list.
Middleton, Gary, Brock, Kristian, Savage, Joshua, Mant, Rhys, Summers, Yvonne, Connibear, John, Shah, Riyaz, Ottensmeier, Christian ORCID: 0000-0003-3619-1657, Shaw, Paul, Lee, Siow-Ming et al (show 4 more authors) , Popat, Sanjay, Barrie, Colin, Barone, Gloria and Billingham, Lucinda (2020) Pembrolizumab in patients with non-small-cell lung cancer of performance status 2 (PePS2): a single arm, phase 2 trial. The Lancet Respiratory Medicine, 8 (9). pp. 895-904.

Collapse authors list.
Copland, Mhairi, Slade, Daniel, McIlroy, Graham, Horne, Gillian, Byrne, Jenny L, Rothwell, Kate, Brock, Kristian, De Lavallade, Hugues, Craddock, Charles, Clark, Richard E ORCID: 0000-0002-1261-3299 et al (show 5 more authors) , Smith, Matthew L, Fletcher, Rachel, Bishop, Rebecca, Milojkovic, Dragana and Yap, Christina (2022) Ponatinib with fludarabine, cytarabine, idarubicin, and granulocyte colony-stimulating factor chemotherapy for patients with blast-phase chronic myeloid leukaemia (MATCHPOINT): a single-arm, multicentre, phase 1/2 trial. LANCET HAEMATOLOGY, 9 (2). E121-E132.